{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.59","value":"4.17"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"description":"To determine the time to maximum concentration (Tmax) of Artesunate (AS) following five consecutive days of self-administration of 200mg Artesunate vaginal inserts (pessaries) among healthy women.\n\nMean DHA Tmax (hours) value will be submitted.","dispersionType":"Standard Deviation","groups":[{"description":"Artesunate vaginal inserts/pessaries are used as a treatment for cervical precancerous lesions.\n\nArtesunate pessary: Subjects will use the study pessaries, placed in the vagina every day for 5 consecutive days.","id":"OG000","title":"Artesunate Vaginal Inserts/ Pessaries"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Day 5","title":"To Determine the Time to Maximum Concentration (Tmax) of Artesunate (AS) Following Five Consecutive Days","type":"SECONDARY","unitOfMeasure":"hours"}